Autonomous Healthcare received FDA De Novo marketing authorization for Syncron-E, a software that supports the assessment of patient-ventilator asynchrony by detecting evidence of ineffective efforts.
The FDA authorized 20 Zyn nicotine pouches, including 10 flavored products, despite concerns from health experts over increased youth use.
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
"ATS Now is like Netflix for pulmonologists," the organization says, offering access to conference highlights, webinars, and educational content for pulmonary and critical care professionals.
Perma Pure and Maxtec have unified under a new parent company, Salaera, to form a global technology platform for breath and gas systems.
Benralizumab (Fasenra) is now indicated to reduce the risk of flare ups for adult and pediatric patients with hypereosinophilic syndrome.
The RAPID coverage pathway aims to reduce delays between FDA authorization and Medicare coverage for breakthrough technologies.